Human HLA-DR mAbs promising against lymphoma

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2002

Schlagwörter:	Alemtuzumab Human Leucocyte Antigen Nature Medicine Antibody Library Human mAbs

Anmerkung:	© Adis International Ltd 2002

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1355(2002), 1 vom: Sept., Seite 7-7
Übergeordnetes Werk:	volume:1355 ; year:2002 ; number:1 ; month:09 ; pages:7-7

Links:	Volltext

DOI / URN:	10.2165/00128413-200213550-00016

Katalog-ID:	SPR035138408

Internformat


LEADER	01000caa a22002652 4500
001	SPR035138408
003	DE-627
005	20230519203422.0
007	cr uuu---uuuuu
008	201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200213550-00016 \|2 doi
035			\|a (DE-627)SPR035138408
035			\|a (SPR)00128413-200213550-00016-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Human HLA-DR mAbs promising against lymphoma
264		1	\|c 2002
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2002
650		4	\|a Alemtuzumab \|7 (dpeaa)DE-He213
650		4	\|a Human Leucocyte Antigen \|7 (dpeaa)DE-He213
650		4	\|a Nature Medicine \|7 (dpeaa)DE-He213
650		4	\|a Antibody Library \|7 (dpeaa)DE-He213
650		4	\|a Human mAbs \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1355(2002), 1 vom: Sept., Seite 7-7 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1355 \|g year:2002 \|g number:1 \|g month:09 \|g pages:7-7
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200213550-00016 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1355 \|j 2002 \|e 1 \|c 09 \|h 7-7

Indexfelder

matchkey_str	article:22306056:2002----::uaharasrmsnaa
hierarchy_sort_str	2002
publishDate	2002
allfields	10.2165/00128413-200213550-00016 doi (DE-627)SPR035138408 (SPR)00128413-200213550-00016-e DE-627 ger DE-627 rakwb eng Human HLA-DR mAbs promising against lymphoma 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Alemtuzumab (dpeaa)DE-He213 Human Leucocyte Antigen (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Antibody Library (dpeaa)DE-He213 Human mAbs (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1355(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1355 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213550-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1355 2002 1 09 7-7
spelling	10.2165/00128413-200213550-00016 doi (DE-627)SPR035138408 (SPR)00128413-200213550-00016-e DE-627 ger DE-627 rakwb eng Human HLA-DR mAbs promising against lymphoma 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Alemtuzumab (dpeaa)DE-He213 Human Leucocyte Antigen (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Antibody Library (dpeaa)DE-He213 Human mAbs (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1355(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1355 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213550-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1355 2002 1 09 7-7
allfields_unstemmed	10.2165/00128413-200213550-00016 doi (DE-627)SPR035138408 (SPR)00128413-200213550-00016-e DE-627 ger DE-627 rakwb eng Human HLA-DR mAbs promising against lymphoma 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Alemtuzumab (dpeaa)DE-He213 Human Leucocyte Antigen (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Antibody Library (dpeaa)DE-He213 Human mAbs (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1355(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1355 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213550-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1355 2002 1 09 7-7
allfieldsGer	10.2165/00128413-200213550-00016 doi (DE-627)SPR035138408 (SPR)00128413-200213550-00016-e DE-627 ger DE-627 rakwb eng Human HLA-DR mAbs promising against lymphoma 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Alemtuzumab (dpeaa)DE-He213 Human Leucocyte Antigen (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Antibody Library (dpeaa)DE-He213 Human mAbs (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1355(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1355 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213550-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1355 2002 1 09 7-7
allfieldsSound	10.2165/00128413-200213550-00016 doi (DE-627)SPR035138408 (SPR)00128413-200213550-00016-e DE-627 ger DE-627 rakwb eng Human HLA-DR mAbs promising against lymphoma 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Alemtuzumab (dpeaa)DE-He213 Human Leucocyte Antigen (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Antibody Library (dpeaa)DE-He213 Human mAbs (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1355(2002), 1 vom: Sept., Seite 7-7 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1355 year:2002 number:1 month:09 pages:7-7 https://dx.doi.org/10.2165/00128413-200213550-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1355 2002 1 09 7-7
language	English
source	Enthalten in Inpharma weekly 1355(2002), 1 vom: Sept., Seite 7-7 volume:1355 year:2002 number:1 month:09 pages:7-7
sourceStr	Enthalten in Inpharma weekly 1355(2002), 1 vom: Sept., Seite 7-7 volume:1355 year:2002 number:1 month:09 pages:7-7
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Alemtuzumab Human Leucocyte Antigen Nature Medicine Antibody Library Human mAbs
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2002-09-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035138408
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035138408</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519203422.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213550-00016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035138408</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213550-00016-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Human HLA-DR mAbs promising against lymphoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alemtuzumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Leucocyte Antigen</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nature Medicine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibody Library</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human mAbs</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1355(2002), 1 vom: Sept., Seite 7-7</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1355</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:7-7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213550-00016</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1355</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">7-7</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Human HLA-DR mAbs promising against lymphoma Alemtuzumab (dpeaa)DE-He213 Human Leucocyte Antigen (dpeaa)DE-He213 Nature Medicine (dpeaa)DE-He213 Antibody Library (dpeaa)DE-He213 Human mAbs (dpeaa)DE-He213
topic	misc Alemtuzumab misc Human Leucocyte Antigen misc Nature Medicine misc Antibody Library misc Human mAbs
spellingShingle	misc Alemtuzumab misc Human Leucocyte Antigen misc Nature Medicine misc Antibody Library misc Human mAbs Human HLA-DR mAbs promising against lymphoma
topic_unstemmed	misc Alemtuzumab misc Human Leucocyte Antigen misc Nature Medicine misc Antibody Library misc Human mAbs
topic_browse	misc Alemtuzumab misc Human Leucocyte Antigen misc Nature Medicine misc Antibody Library misc Human mAbs
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Human HLA-DR mAbs promising against lymphoma
ctrlnum	(DE-627)SPR035138408 (SPR)00128413-200213550-00016-e
title_full	Human HLA-DR mAbs promising against lymphoma
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2002
contenttype_str_mv	txt
container_start_page	7
container_volume	1355
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200213550-00016
title_sort	human hla-dr mabs promising against lymphoma
title_auth	Human HLA-DR mAbs promising against lymphoma
abstract	© Adis International Ltd 2002
abstractGer	© Adis International Ltd 2002
abstract_unstemmed	© Adis International Ltd 2002
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Human HLA-DR mAbs promising against lymphoma
url	https://dx.doi.org/10.2165/00128413-200213550-00016
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200213550-00016
up_date	2024-07-03T13:43:27.651Z
_version_	1803565617807097856
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035138408</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519203422.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213550-00016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035138408</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213550-00016-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Human HLA-DR mAbs promising against lymphoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alemtuzumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Leucocyte Antigen</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nature Medicine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibody Library</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human mAbs</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1355(2002), 1 vom: Sept., Seite 7-7</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1355</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:7-7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213550-00016</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1355</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">09</subfield><subfield code="h">7-7</subfield></datafield></record></collection>
score	7.4016857

Nicht das Richtige dabei?

Schreiben Sie uns!

Human HLA-DR mAbs promising against lymphoma

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?